Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • ANDROGEN-RECEPTOR  (1)
  • ANTAGONISTS  (1)
  • BIOLOGY  (1)
  • 1
    Keywords: OPTIMIZATION ; RECEPTOR ; CELLS ; IN-VITRO ; CELL ; COMBINATION ; VITRO ; GENE ; GENES ; BIOLOGY ; ASSAY ; CELL-LINE ; LINE ; NETHERLANDS ; RECEPTORS ; ER ; signaling ; SCIENCE ; methods ; ANDROGEN RECEPTOR ; CHEMICALS ; ANTAGONISTS ; ANDROGEN ; androgens ; in vitro ; reporter gene assay ; RANGE ; ANDROGEN-RECEPTOR ; PANEL ; Prevalidation ; ENDOCRINE DISRUPTORS ; REPORTER ; Hershberger assay ; Androgen reporter gene assay ; BIOASSAYS ; HUMAN CELL-LINE
    Abstract: To date there are no validated methods available to test androgenicity or antiandrogenicity in vitro. A problem with testing androgenicity using reporter genes is the possibility by other steroid receptors than androgen receptors to activate the same reporter gene, thereby lowering selectivity. To avoid this we have established a robust and very selective method, the AR CALUX reporter gene assay, to test androgenic and antiandrogenic activity of compounds in vitro. This assay uses a human U2-OS cell line stably transfected with the human androgen receptor and an androgen receptor responsive reporter gene. We optimized protocols to be used in combination with AR CALUX cells and carried out an in house prevalidation. In addition we successfully transferred this assay to another laboratory, leading to comparable test results with a panel of androgen receptor agonists and antagonists. The assay was able to readily rank a range of chemicals on the basis of their EC50 values. The CALUX assay was found to be selective for androgens and seemed not influenced by signaling through other steroid receptors.
    Type of Publication: Journal article published
    PubMed ID: 20438827
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...